KLWA
HALO icon

Kelly Lawrence W & Associates’s Halozyme HALO Stock Holding History

Kelly Lawrence W & Associates’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$117K Buy
+1,500
New +$102K 0.03% 94

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Kelly Lawrence W & Associates's HALO Position: Q2 2026 in Review

Kelly Lawrence W & Associates opened a new position in Halozyme (HALO) in Q2 2026: 1,500 shares worth $117K. The stake represents 0.03% of the portfolio and ranks #94 among its holdings.

668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Kelly Lawrence W & Associates held 1,500 shares of Halozyme worth $117K as of Q2 2026.
  • Halozyme was a new Kelly Lawrence W & Associates position in Q2 2026.
  • Halozyme made up 0.03% of Kelly Lawrence W & Associates's portfolio in Q2 2026, its #94 holding.
  • 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Kelly Lawrence W & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.